Please login to the form below

Not currently logged in
Email:
Password:

Ex-Pfizer executive Ed Mascioli joins Affinium as CEO

Robert Radie also appointed to board of directors

Ex-Pfizer executive Ed Mascioli joins Affinium as CEOAffinium Pharmaceuticals has appointed former Pfizer senior executive Ed Mascioli as its new CEO.

Mascioli (pictured right) served as head of Pfizer's orphan and genetic diseases unit from 2010 to 2012, where his accomplishments included a $210m deal with Zacharon to develop drugs for orphan diseases.

Prior to his time at Pfizer, Mascioli was chief medical officer at Peptimmune – a spin-out from Genzyme that developed the investigational multiple sclerosis treatment PI-2301 ahead of the compound's acquisition by Merck KGaA in 2011.

He has also held a senior position at Parexel and was the founder of the Boston Center of Nutrition.

Mascioli is joined at Affinium by another newcomer, Robert Radie, who is appointed to the board of directors.

Radie is currently president and CEO of Egalet, a specialty pharmaceutical company developing tamper-resistant pain medicines.

The appointments come as Affinium prepares to progress the development of its antibiotic AFN-1252 for staphylococcal infections.

According to the company, the oral formulation of AFN-1252 is finishing phase IIa trials, and the intravenous formulation is completing pre-clinical studies.

18th March 2013

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story
How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
AI healthcare
Three ways AI will change healthcare in the next decade
Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...

Infographics